Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study

INTRODUCTION: COVID-19 induces coagulopathy associated with an increase of thromboembolic events. Due to the lack of agreement on recommendations for thromboprophylactic management, the aim of this study was to study the dosages of LMWH used in critically ill COVID-19 patients assessing the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrandis, R., Escontrela, B., Ferrando, C., Hernández, M., Herrera, J., Hidalgo, F., Librero, J., Llau, J.V., Martínez, A., Pajares, A., Tapia, B., Arruti, E., Bassas, E., Blasi, A., Calvo, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957653/
https://www.ncbi.nlm.nih.gov/pubmed/36842685
http://dx.doi.org/10.1016/j.redare.2023.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957653/
https://www.ncbi.nlm.nih.gov/pubmed/36842685
http://dx.doi.org/10.1016/j.redare.2023.02.004

Ejemplares similares